SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-094060
Filing Date
2023-12-07
Accepted
2023-12-07 16:09:39
Documents
15
Period of Report
2023-12-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea189647-8k_biomx.htm   iXBRL 8-K 38768
2 CONSENT OF KESSELMAN & KESSELMAN, CERTIFIED PUBLIC ACCOUNTANTS (ISR.), A MEMBER ea189647ex23-1_biomxinc.htm EX-23.1 3134
3 FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA ea189647ex99-1_biomxinc.htm EX-99.1 444316
  Complete submission text file 0001213900-23-094060.txt   773890

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE phge-20231207.xsd EX-101.SCH 3919
5 XBRL DEFINITION FILE phge-20231207_def.xml EX-101.DEF 26852
6 XBRL LABEL FILE phge-20231207_lab.xml EX-101.LAB 37202
7 XBRL PRESENTATION FILE phge-20231207_pre.xml EX-101.PRE 25476
9 EXTRACTED XBRL INSTANCE DOCUMENT ea189647-8k_biomx_htm.xml XML 5709
Mailing Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003 (972) 72 394 2377
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38762 | Film No.: 231472456
SIC: 2836 Biological Products, (No Diagnostic Substances)